ReviewGastro hep advances2025

Food and Drug Administration Approval Summary: Odevixibat (Bylvay) for the Treatment of Pruritus With Progressive Familial Intrahepatic Cholestasis.

Sojeong Yi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.